Diamedica Therapeutics Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on February 26, 2019, by Diamedica Therapeutics Inc., a company incorporated in Canada. The report addresses Item 8.01 (Other Events) regarding the scheduling of the company's 2019 Annual and Special Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The primary event is the administrative scheduling of a shareholder meeting.
Guidance, Outlook, and Management Commentary
The Board of Directors established the following details for the 2019 Annual and Special Meeting of Shareholders:
- Date: Wednesday, May 22, 2019
- Time: 2:30 p.m. Central Time
- Location: Fox Rothschild LLP, 222 South Ninth Street, Suite 2000, Minneapolis, Minnesota 55402
- Record Date: Shareholders of record at the close of business on March 28, 2019, are entitled to notice and to vote.
The filing does not contain specific guidance, risk factors, or unusual items beyond the meeting logistics.
Investor Verification Checklist
- Verify the record date of March 28, 2019, to confirm voting eligibility.
- Confirm the meeting agenda and proxy statement details in subsequent filings (e.g., DEF 14A).
- Review the company's latest 10-K or 10-Q for financial performance data not included in this 8-K.